Denali Therapeutics Inc.DNLINASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-487.34M
↓ 185% below average
Average (9y)
$-171.16M
Historical baseline
Range
High:$62.72M
Low:$-487.34M
CAGR
+45.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-487.34M | -147.8% |
| 2023 | $-196.70M | +42.3% |
| 2022 | $-340.74M | -15.2% |
| 2021 | $-295.75M | -571.6% |
| 2020 | $62.72M | +129.4% |
| 2019 | $-213.18M | -359.7% |
| 2018 | $-46.37M | +48.6% |
| 2017 | $-90.14M | -3.1% |
| 2016 | $-87.43M | -424.2% |
| 2015 | $-16.68M | - |